Investigating the effect of CoCl2 administration on diabetic nephropathy and associated aortic dysfunction

Kidney Blood Press Res. 2012;35(6):694-7. doi: 10.1159/000343888. Epub 2013 Jan 9.

Abstract

Aim: Endothelial dysfunction appears to be a consistent finding in diabetic nephropathy. The study aimed to investigate the effect of cobalt chloride in the amelioration of endothelial dysfunction in uninephrectomized diabetic rats.

Methods: We examined the effect of CoCl(2) (10 mg/kg, i.p., OD = once a day) treatment on contractile responses to angiotensin II (10(-10) to 10(-6)M) in an aortic preparation of control rats and uninephrectomized diabetic control rats. Blood glucose, plasma urea, creatinine, uric acid, aortic endothelial nitric oxide synthase (eNOS), nitrate/nitrite (NOx), superoxide dismutase, catalase and reduced glutathione levels were checked in the different groups.

Results: A significant attenuation of the augmented responses to angiotensin II was observed in CoCl(2)-treated animals along with a fall in plasma urea, creatinine and uric acid levels. A significant reduction in blood glucose and an increase in aortic eNOS and NOx levels along with antioxidants levels were observed.

Conclusion: Chronic hypoxia augments angiotensin II responses in the thoracic aorta of uninephrectomized diabetic control rats. CoCl(2) attenuates these enhanced vascular responses with a significant decrease in blood glucose signifying stabilization of the hypoxia-inducible factor in the alleviation of endothelial dysfunction in diabetic nephropathy.

MeSH terms

  • Animals
  • Aorta, Thoracic / drug effects*
  • Aorta, Thoracic / physiopathology*
  • Cobalt / pharmacology
  • Cobalt / therapeutic use*
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / physiopathology*
  • Rats
  • Rats, Sprague-Dawley
  • Treatment Outcome

Substances

  • Cobalt
  • cobaltous chloride